Cargando…

Participant Preferences for the Provision of Registration Trials Results

BACKGROUND: Clinical trials leading to drug approval (registration trials) play a central role in the drug development process, and attention has recently been paid to providing trial results to participants. In the present study, we examined the preferences of participants of registration trials fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tajima, Soichiro, Akaishi, Akiyo, Miyamoto, Toshiko, Katashima, Rumi, Nakai, Kenichi, Mitsui, Takao, Yanagawa, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748666/
https://www.ncbi.nlm.nih.gov/pubmed/23976914
http://dx.doi.org/10.4021/jocmr1494w
_version_ 1782281104433086464
author Tajima, Soichiro
Akaishi, Akiyo
Miyamoto, Toshiko
Katashima, Rumi
Nakai, Kenichi
Mitsui, Takao
Yanagawa, Hiroaki
author_facet Tajima, Soichiro
Akaishi, Akiyo
Miyamoto, Toshiko
Katashima, Rumi
Nakai, Kenichi
Mitsui, Takao
Yanagawa, Hiroaki
author_sort Tajima, Soichiro
collection PubMed
description BACKGROUND: Clinical trials leading to drug approval (registration trials) play a central role in the drug development process, and attention has recently been paid to providing trial results to participants. In the present study, we examined the preferences of participants of registration trials for the provision of trial-related information. METHODS: We used questionnaires to survey the preferences of registration trial participants at Tokushima University Hospital and Tokushima National Hospital. Of the 15 questions, 6 related to participant characteristics and the trials in which they participated, while 9 questions were concerned with preferences for the provision of information. A five-point scale (strongly agree, agree, neutral, disagree, and strongly disagree) was used, and positive answers (strongly agree and agree) were considered to indicate a positive preference. RESULTS: Of the 58 subjects, 1 declined, giving a response rate of 98%. More than 70% of participants preferred to obtain information, even if they had served as controls. More than 80% of participants agreed to obtain information relating to trial results, even if the results were negative, and more than 80% of participants agreed to obtain information on the labeling state of the agent, even if development had ceased. Although more than 60% of participants agreed for the provision of information on their allocation and around more than 70% agreed to the provision of information on registration trials status, significantly fewer participants with difficult-to-treat diseases (for example, neurological and malignant diseases) agreed to obtain information compared with participants with other types of diseases (for example, acute, chronic, and psychological diseases). More than 50% of participants desired information to be provided directly by the physician, while a considerable number of participants desired information by means of clinical research coordinators (CRCs) (24.4%) or by posted letter (33.3%). CONCLUSION: The present results suggest the preferences for the provision of individual and overall information concerning research results. However, further study is warranted to determine participant preferences more precisely and the effect of the CRC-initiated infrastructure for providing information on patient satisfaction and for promoting registration trials.
format Online
Article
Text
id pubmed-3748666
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-37486662013-08-23 Participant Preferences for the Provision of Registration Trials Results Tajima, Soichiro Akaishi, Akiyo Miyamoto, Toshiko Katashima, Rumi Nakai, Kenichi Mitsui, Takao Yanagawa, Hiroaki J Clin Med Res Original Article BACKGROUND: Clinical trials leading to drug approval (registration trials) play a central role in the drug development process, and attention has recently been paid to providing trial results to participants. In the present study, we examined the preferences of participants of registration trials for the provision of trial-related information. METHODS: We used questionnaires to survey the preferences of registration trial participants at Tokushima University Hospital and Tokushima National Hospital. Of the 15 questions, 6 related to participant characteristics and the trials in which they participated, while 9 questions were concerned with preferences for the provision of information. A five-point scale (strongly agree, agree, neutral, disagree, and strongly disagree) was used, and positive answers (strongly agree and agree) were considered to indicate a positive preference. RESULTS: Of the 58 subjects, 1 declined, giving a response rate of 98%. More than 70% of participants preferred to obtain information, even if they had served as controls. More than 80% of participants agreed to obtain information relating to trial results, even if the results were negative, and more than 80% of participants agreed to obtain information on the labeling state of the agent, even if development had ceased. Although more than 60% of participants agreed for the provision of information on their allocation and around more than 70% agreed to the provision of information on registration trials status, significantly fewer participants with difficult-to-treat diseases (for example, neurological and malignant diseases) agreed to obtain information compared with participants with other types of diseases (for example, acute, chronic, and psychological diseases). More than 50% of participants desired information to be provided directly by the physician, while a considerable number of participants desired information by means of clinical research coordinators (CRCs) (24.4%) or by posted letter (33.3%). CONCLUSION: The present results suggest the preferences for the provision of individual and overall information concerning research results. However, further study is warranted to determine participant preferences more precisely and the effect of the CRC-initiated infrastructure for providing information on patient satisfaction and for promoting registration trials. Elmer Press 2013-10 2013-08-05 /pmc/articles/PMC3748666/ /pubmed/23976914 http://dx.doi.org/10.4021/jocmr1494w Text en Copyright 2013, Tajima et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Tajima, Soichiro
Akaishi, Akiyo
Miyamoto, Toshiko
Katashima, Rumi
Nakai, Kenichi
Mitsui, Takao
Yanagawa, Hiroaki
Participant Preferences for the Provision of Registration Trials Results
title Participant Preferences for the Provision of Registration Trials Results
title_full Participant Preferences for the Provision of Registration Trials Results
title_fullStr Participant Preferences for the Provision of Registration Trials Results
title_full_unstemmed Participant Preferences for the Provision of Registration Trials Results
title_short Participant Preferences for the Provision of Registration Trials Results
title_sort participant preferences for the provision of registration trials results
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748666/
https://www.ncbi.nlm.nih.gov/pubmed/23976914
http://dx.doi.org/10.4021/jocmr1494w
work_keys_str_mv AT tajimasoichiro participantpreferencesfortheprovisionofregistrationtrialsresults
AT akaishiakiyo participantpreferencesfortheprovisionofregistrationtrialsresults
AT miyamototoshiko participantpreferencesfortheprovisionofregistrationtrialsresults
AT katashimarumi participantpreferencesfortheprovisionofregistrationtrialsresults
AT nakaikenichi participantpreferencesfortheprovisionofregistrationtrialsresults
AT mitsuitakao participantpreferencesfortheprovisionofregistrationtrialsresults
AT yanagawahiroaki participantpreferencesfortheprovisionofregistrationtrialsresults